Radiofrequency ablation of unresectable hepatic tumors. [electronic resource]
Producer: 20040409Description: 19-23 p. digitalISSN:- 1543-1622
- Blue Cross Blue Shield Insurance Plans
- Catheter Ablation -- adverse effects
- Device Approval
- Humans
- Insurance Coverage
- Liver Neoplasms -- secondary
- Neoplasm Recurrence, Local
- Outcome Assessment, Health Care
- Randomized Controlled Trials as Topic
- Technology Assessment, Biomedical
- United States
- United States Food and Drug Administration
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.